Qiong Yang
Beijing Key Laboratory Of Gene Resource And Molecular Development
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
The roles of RUNX1 in megakaryocyte differentiation in myeloid leukemia.
Journal: Leukemia & lymphoma
Published: August 24, 2026
The effect of U2AF1 mutation on erythroid differentiation and sensitivity to demethylation drug treatment.
Journal: Medical oncology (Northwood, London, England)
Published: May 07, 2025
Notch1 activation and inhibition in T-cell acute lymphoblastic leukemia subtypes.
Journal: Experimental hematology
Published: September 17, 2024
The treatment landscape of triple-negative breast cancer.
Journal: Medical oncology (Northwood, London, England)
Published: July 18, 2024
Current status and new experimental diagnostic methods of invasive fungal infections after hematopoietic stem cell transplantation.
Journal: Archives of microbiology
Published: January 24, 2024
Updates in Laboratory Identification of Invasive Fungal Infection in Neonates.
Journal: Microorganisms
Published: March 10, 2023
Fasudil promotes polyploidization of megakaryoblasts in an acute megakaryocyte leukemia model.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 13, 2023
The roles of EZH2 in cancer and its inhibitors.
Journal: Medical oncology (Northwood, London, England)
Published: January 26, 2023
Differentiation therapy for murine myelofibrosis model with MLN8237 loaded low-density lipoproteins.
Differentiation therapy for murine myelofibrosis model with MLN8237 loaded low-density lipoproteins.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 28, 2022
Recent Development of LDL-Based Nanoparticles for Cancer Therapy.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 21, 2022
Heat shock protein 90 inhibitors induce cell differentiation via the ubiquitin-dependent aurora kinase A degradation in a MPLW515L mouse model of primary myelofibrosis.
Journal: Hematological oncology
Published: June 11, 2022
Combination of AURKA inhibitor and HSP90 inhibitor to treat breast cancer with AURKA overexpression and TP53 mutations.
Journal: Medical oncology (Northwood, London, England)
Published: May 09, 2022
Last Updated: 09/26/2026